Galectin-3 induces ovarian cancer cell survival and chemoresistance via TLR4 signaling activation

Galectin-3 is a sensor-regulator of toll-like receptor pathways in synovial fibroblasts

(2015) Uri Arad et al.   CYTOKINE

Extracellular galectin-3 programs multidrug resistance through Na+/K+-ATPase and P-glycoprotein signaling

(2015) Yosuke Harazono et al.   Oncotarget

Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation

(2015) Miguel Angel Burguillos et al.   Cell Reports

Galectin-3: a possible complementary marker to the PSA blood test

(2015) Vitaly Balan et al.   Oncotarget

Synergistic Effects of PectaSol-C Modified Citrus Pectin an Inhibitor of Galectin-3 and Paclitaxel on Apoptosis of Human SKOV-3 Ovarian Cancer Cells

(2014) Ghamartaj Hossein et al.   Asian Pacific Journal of Cancer Prevention

Paclitaxel Therapy Promotes Breast Cancer Metastasis in a TLR4-Dependent Manner

(2014) L. Volk-Draper et al.   CANCER RESEARCH

Galectin-3 in cancer

(2014) Lin Song et al.   CLINICA CHIMICA ACTA

Galectin-3 inhibition suppresses drug resistance, motility, invasion and angiogenic potential in ovarian cancer

(2014) Leonardo Mirandola et al.   GYNECOLOGIC ONCOLOGY

Oncogenes associated with drug resistance in ovarian cancer

(2014) Xia Liu et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Ovarian cancer

(2014) Gordon C Jayson et al.   LANCET

Serum galectin-3 levels in women with PCOS

(2014) H. Yilmaz et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide

(2013) Kevin Quann et al.   CELL CYCLE

In vitro fertilization is associated with an increased risk of borderline ovarian tumours

(2013) Louise M. Stewart et al.   GYNECOLOGIC ONCOLOGY

Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy

(2013) Marta Smoter et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Caveolin-1 Tyr14 Phosphorylation Induces Interaction with TLR4 in Endothelial Cells and Mediates MyD88-Dependent Signaling and Sepsis-Induced Lung Inflammation

(2013) H. Jiao et al.   JOURNAL OF IMMUNOLOGY

TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer

(2013) S. Rajput et al.   MOLECULAR CANCER THERAPEUTICS

Galectin-3 – A jack-of-all-trades in cancer

(2011) Anna U. Newlaczyl et al.   CANCER LETTERS

Serum Galectin-2, -4, and -8 Are Greatly Increased in Colon and Breast Cancer Patients and Promote Cancer Cell Adhesion to Blood Vascular Endothelium

(2011) H. Barrow et al.   CLINICAL CANCER RESEARCH

Clinical relevance of extent of extreme drug resistance in epithelial ovarian carcinoma

(2009) Koji Matsuo et al.   GYNECOLOGIC ONCOLOGY

The Heme Oxygenase-1/Carbon Monoxide Pathway Suppresses TLR4 Signaling by Regulating the Interaction of TLR4 with Caveolin-1

(2009) X. M. Wang et al.   JOURNAL OF IMMUNOLOGY

TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer

(2009) M Szajnik et al.   ONCOGENE

Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance

(2007) R. SALANI et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER